Related Experiment Video
Updated: Feb 28, 2026
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Berberine improves colon damage of ulcerative colitis colonic epithelium by activating TAS2R38 signaling pathway
Bingyu Chen1, Ke Liu2, Yanhua Wang1
1Department of Geratology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Background:
Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease. Current treatment options have limitations in terms of efficacy and side effects. TAS2R38 is an important bitter taste receptor, and recent studies have suggested its potential role in gut immune regulation. This study aims to explore the role of the TAS2R38 receptor in UC and evaluate its potential as a therapeutic target.
Methods:
A 3% DSS solution was used to induce colitis in mice. The expression of TAS2R38 and its downstream signaling pathway was assessed using immunohistochemistry, Western blot, and immunofluorescence. Through molecular docking and pharmacological screening, bitter compounds, that bind to TAS2R38 were identified. The therapeutic effects of bitter compounds on DSS-induced colitis were evaluated by monitoring body weight, measuring colon length, conducting HE staining, and assessing the mucus layer integrity.
Results:
In the DSS-induced colitis mouse model, the TAS2R38 signaling pathway was found to be inhibited, particularly with a significant reduction in the expression of the downstream proteins PLCβ2 and IP3R3. Pharmacological screening and molecular dynamics simulations revealed that berberine strongly binds to TAS2R38 and effectively prevents DSS-induced colitis by activating this receptor. Berberine treatment significantly alleviated symptoms such as weight loss, diarrhea, and fecal occult blood, and improved colon length, spleen weight, and disease activity index (DAI). Additionally, HE staining showed that berberine significantly reduced DSS-induced epithelial damage and restored intestinal mucus barrier integrity.
Conclusion:
This study suggests that the TAS2R38 receptor may play a key role in the pathogenesis of ulcerative colitis. Berberine, by activating the TAS2R38 signaling pathway, exerts significant protective effects in DSS-induced colitis. TAS2R38 could be a potential therapeutic target for UC, and berberine, as a traditional Chinese medicine component, holds promise as a treatment for UC.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:28Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.